Literature DB >> 7485733

Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy.

C J O'Brien1, R F Uren, J F Thompson, R B Howman-Giles, K Petersen-Schaefer, H M Shaw, M J Quinn, W H McCarthy.   

Abstract

BACKGROUND: The technique of lymphoscintigraphy may allow a more selective approach to the management of clinically negative neck nodes among patients with cutaneous head and neck melanoma. PATIENTS AND METHODS: A group of 97 patients with cutaneous head and neck melanoma had preoperative lymphoscintigraphy using intradermal injections of technetium 99m antimony trisulfide colloid to identify sentinel nodes. Fifty-one patients were eligible for clinical analysis after initial definitive treatment by wide excision only (n = 11), wide excision and elective dissection of the neck (n = 19) or axilla (n = 1), or wide excision and a sentinel node biopsy procedure (n = 20).
RESULTS: Sentinel nodes were identified in 95 of 97 lymphoscintigrams, and 85% of patients had multiple sentinel nodes. In 21 patients (22%), sentinel nodes were identified outside the parotid region and the 5 main neck levels, mostly in postauricular nodes (n = 13). Lymphoscintigrams were discordant with clinical predictions in 33 patients (34%). Lymph nodes were positive in 4 elective dissections and 4 sentinel node biopsies. Among 16 patients evaluable after wide excision and a negative sentinel node biopsy, 4 patients subsequently developed metastatic nodes; however, confident identification of all nodes marked as sentinel nodes on lymphoscintigraphy was not achieved at the original biopsy procedure in 3 of these patients.
CONCLUSIONS: Lymphoscintigraphy and sentinel node biopsy are more difficult to perform in the head and neck than in other parts of the body. The reliability of sentinel node biopsy based on lymphoscintigraphy may be improved by identifying and marking all nodes that are considered to receive direct lymphatic drainage from the primary melanoma, and by use of a gamma probe intraoperatively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485733     DOI: 10.1016/s0002-9610(99)80330-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  25 in total

Review 1.  Management of cervical metastasis.

Authors:  Eric J Lentsch
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

Review 2.  Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature.

Authors:  Sofiane Maza; Uwe Trefzer; Maja Hofmann; Silke Schneider; Christiane Voit; Thomas Krössin; Andreas Zander; Heike Audring; Wolfram Sterry; Dieter L Munz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-24       Impact factor: 9.236

3.  Dominant lymph drainage in the facial region: evaluation of lymph nodes of facial melanoma patients.

Authors:  Toshihiko Hayashi; Hiroshi Furukawa; Akihiko Oyama; Emi Funayama; Akira Saito; Yuhei Yamamoto
Journal:  Int J Clin Oncol       Date:  2011-08-05       Impact factor: 3.402

4.  Sentinel lymph node biopsy in cutaneous head and neck melanoma.

Authors:  D Evrard; E Routier; C Mateus; G Tomasic; J Lombroso; F Kolb; C Robert; A Moya-Plana
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-19       Impact factor: 2.503

Review 5.  Oral cavity squamous cell carcinoma and the clinically n0 neck: the past, present, and future of sentinel lymph node biopsy.

Authors:  Andrew Coughlin; Vicente A Resto
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

Review 6.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

7.  Tumor location predicts survival in cutaneous head and neck melanoma.

Authors:  Warren H Tseng; Steve R Martinez
Journal:  J Surg Res       Date:  2010-11-10       Impact factor: 2.192

8.  A false-negative sentinel lymph node in the parotid gland of a melanoma patient: a new algorithm for SLN biopsy in the parotid gland.

Authors:  Toshihiko Hayashi; Hiroshi Furukawa; Arata Tsutsumida; Tetsunori Yoshida
Journal:  Int J Clin Oncol       Date:  2010-03-16       Impact factor: 3.402

9.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

Authors:  D L Morton; J F Thompson; R Essner; R Elashoff; S L Stern; O E Nieweg; D F Roses; C P Karakousis; N Mozzillo; D Reintgen; H J Wang; E C Glass; A J Cochran
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

10.  Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary?

Authors:  Sergi Vidal-Sicart; Francesca Pons; Silvia Fuertes; Antonio Vilalta; Ramón Rull; Susana Puig; Josep M Palou; Marisa Ortega; Teresa Castel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.